[IR Material] Macquarie Securities Korea NDR (Hong Kong / Singapore) — ST PHARM

Science & Technology
- Business Overview
- CDMO
- CRO
  - AnaPath Research & Service
- R&D
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

IR Materials

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

IR Materials

Nov 1, 2024

[IR Material] Macquarie Securities Korea NDR (Hong Kong / Singapore)

「반출」ST PHARM_IR(24.11).pdf